BCBA/UNH (BCBA/UNH)

Buenos Aires Stock Exchange: BCBA/UNH · ARS

ARS 20,420

+719.08 (+3.6%)· Recorded snapshot

Market cap	564.1T
Revenue (ttm)	686.3T
Net income (ttm)	24.2T
EPS (ttm)	ARS 818
P/E (trailing)	25.0x
P/E (forward)	18.3x
Dividend	ARS 258 (1.26%)
Volume	31,135

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 686.3T
Net income (ttm): 24.2T
EPS (ttm): ARS 818
P/E (trailing): 25.0x
P/E (forward): 18.3x
Market cap: 564.1T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.3

P25 n/aP50 n/aP75 n/a

Trailing P/E25

P25 n/aP50 n/aP75 n/a

ROE15.8

P25 n/aP50 n/aP75 n/a

ROIC12.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/UNH indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

USD

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-13
Employees	390,000
Employees change	-10,000
Employees growth	-2.5%
Enterprise value	ARS 640.9T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1974
Industry	Healthcare Plans
Is primary listing	No
ISIN number	ARBCOM460390
Last earnings date	2026-10-13
Last refreshed	2026-10-28
Market cap	ARS 564.1T
Next earnings date	2027-01-12
Price	ARS 20,420.00
Price currency	ARS
Sector	Healthcare
SIC code	6324
Stock price date	2026-10-28
Symbol	bcba/UNH
Website	https://www.unitedhealthgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	22.39x
Average P/E ratio (3Y)	25.01x
Average P/E ratio (5Y)	24.72x
Earnings yield	4%
EV/Earnings	26.56x
EV/EBIT	15.88x
EV/EBITDA	13.71x
EV/FCF	18.48x
EV/Sales	0.93x
FCF / EV yield	5.41%
FCF yield	6.14%
Forward P/E	18.29x
Graham number	10673.26285
Graham upside	-47.73%
Lynch fair value	ARS 4,364.53
Lynch upside	-78.63%
P/(FCF - SBC) ratio	17.04x
P/(OCF - SBC) ratio	14.76x
P/B ratio	3.52x
P/E ratio	24.98x
P/FCF ratio	16.28x
P/OCF ratio	14.19x
P/S ratio	0.83x
Price / tangible book value	3.57x
Price/EBITDA ratio	12.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	5.85%
EBITDA margin	6.42%
Effective tax rate	15.54%
FCF margin	5.02%
Gross margin	20.05%
Operating margin	5.85%
Pretax margin	4.38%
Profit margin	3.53%
Profit per employee	ARS 62.1M
Profitable quarters	10
Profitable years	27
Revenue per employee	ARS 1.8B
ROA	5.24%
ROA (5Y)	6.86%
ROCE	13.38%
ROE	15.77%
ROE (5Y)	20.42%
ROIC	12.39%
ROIC (5Y)	14.86%
SBC / revenue	0.23%
Tax / revenue	0.68%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-8.96%
EPS growth (Q)	75.93%
EPS growth (QoQ)	-24.56%
EPS growth 10Y	9.96%
EPS growth 3Y	-8.76%
EPS growth 5Y	1.66%
EPS growth quarters	2
EPS growth years	0
FCF growth	31.4%
FCF growth (Q)	-15.65%
FCF growth (QoQ)	-58.41%
FCF growth 3Y	-4.78%
FCF growth 5Y	-0.06%
Net income growth	-9.69%
Net income growth (Q)	75.04%
Net income growth (QoQ)	-25.05%
Net income growth 3Y	-9.86%
Net income growth 5Y	0.59%
Net income growth quarters	3
Net income growth years	0
OCF growth	24.99%
OCF growth (Q)	-13.83%
OCF growth (QoQ)	-53.65%
OCF growth 10Y	5.94%
OCF growth 3Y	-4.13%
OCF growth 5Y	0.76%
Revenue growth	3.42%
Revenue growth (Q)	-0.41%
Revenue growth (QoQ)	0.59%
Revenue growth 10Y	9.54%
Revenue growth 3Y	7.73%
Revenue growth 5Y	10.01%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -5.1T
EBIT	ARS 40.2T
EBITDA	ARS 44.1T
EPS	ARS 817.60
Financing cash flow	ARS -24.5T
Free cash flow	ARS 34.8T
Free cash flow minus SBC	ARS 33.3T
Gross profit	ARS 137.6T
Income taxes	ARS 4.7T
Investing cash flow	ARS -17.4T
Net borrowing	ARS -7.4T
Net cash flow	ARS -2.1T
Net income	ARS 24.2T
Operating cash flow minus SBC	ARS 38.4T
Operating income	ARS 40.2T
Revenue	ARS 686.3T
Stock-based compensation	ARS 1.6T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	ARS 176,038.04
Debt / EBITDA	2.44
Debt / equity	0.7
Debt / FCF	3.26
Interest coverage	6.84
Net cash (debt)	ARS -73.9T
Net cash / market cap	-13.05%
Net debt / EBITDA	1.68
Net debt / equity	0.46
Net debt / FCF	2.12
Piotroski F-Score	6
Shareholders' equity	ARS 160.9T
Tangible book value	ARS 158.8T
Tangible book value per share	ARS 176,038.04
Total assets	ARS 477T
Total cash	ARS 43.5T
Total debt	ARS 113.3T
Total liabilities	ARS 316T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.43
Current ratio	0.74
Net working capital	ARS -77T
Quick ratio	0.42
Working capital	ARS -46.1T

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.98%
Dividend growth	28.97%
Dividend growth (3Y)	87.8%
Dividend growth years	4
Dividend payment date	2026-09-22
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	ARS 258.35
Dividend yield	1.27%
Ex-dividend date	2026-09-14
Last dividend	ARS 68.98
Payout ratio	51.45%
Shareholder yield	2.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 18,013.60
1D price change	3.65%
1M price change	10.8%
1M total return	10.8%
1W price change	-0.97%
1W total return	-0.97%
1Y price change	27.22%
1Y return CAGR	29.33%
1Y total return	29.31%
20-day SMA	ARS 19,424.50
200-day SMA	ARS 16,898.10
3M price change	1.74%
3M total return	2.12%
3Y price change	55.1%
3Y return CAGR	17.18%
3Y total return	60.94%
50-day SMA	ARS 19,006.20
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 21,800.00
52-week high date	2026-07-16
52-week low	ARS 11,360.00
52-week low date	2026-03-27
5Y price change	635.22%
5Y return CAGR	50.43%
5Y total return	670.14%
6M price change	25.81%
6M total return	26.74%
All-time high	ARS 25,025.00
All-time high date	2025-04-11
All-time low	ARS 1,520.00
All-time low date	2021-03-11
Average true range (ATR)	ARS 615.28
Average volume	26.7K
Change from 52-week high	-6.33%
Change from 52-week low	79.75%
Change from all-time high	-18%
Change from all-time low	1,250%
Change from open	0.79%
Day's gap	2.84%
Dollar volume	ARS 635.8M
High price	ARS 20,890.00
Low price	ARS 20,260.00
Monthly RSI	60.72
Open price	ARS 20,260.00
Position in 52-week range	25.4%
Previous close	ARS 19,700.00
Price vs 150-day SMA	13.91%
Price vs 20-day SMA	5.64%
Price vs 200-day SMA	21.43%
Price vs 50-day SMA	7.96%
Relative volume	1.17
RSI	64.32
Sharpe ratio	0.69
Sharpe ratio (3Y)	0.59
Sharpe ratio (5Y)	1.17
Sortino ratio	1.09
Sortino ratio (3Y)	0.9
Sortino ratio (5Y)	1.76
Volume	31.1K
Weekly RSI	64.93
YTD price change	34.21%
YTD total return	35.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	895M
Shares change (QoQ)	-0.44%
Shares change (YoY)	-0.98%
Shares held by insiders	0.17%
Shares held by institutions	88.98%
Short ratio	2.8 days

Deeper analysis on BCBA/UNH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/UNH report

Is a complete BCBA/UNH research report available?

No complete published report is available for bcba/UNH (BCBA/UNH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/UNH (BCBA/UNH)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/UNH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/UNH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/UNH

Frequently asked questions